Inozyme Pharma (NASDAQ:INZY) Given Hold Rating at Jefferies Financial Group
Jefferies Financial Group restated their hold rating on shares of Inozyme Pharma (NASDAQ:INZY – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $4.00 price objective on the stock, down from their prior price objective of $15.00. INZY has been the subject of a number of other reports. […]
Jefferies Financial Group restated their hold rating on shares of Inozyme Pharma (NASDAQ:INZY – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $4.00 price objective on the stock, down from their prior price objective of $15.00. INZY has been the subject of a number of other reports. […]
